Get notified of page updates
Clinicaltrials.gov identifier:
NCT02401347
Study Contact Information:
The study is being conducted by researchers at Stanford University Hospital. Contact Pei Jen Chang by phone at 310-967-4339 or by email.
Talazoparib Beyond BRCA (TBB) Trial
About the Study
The goal of the study is to evaluate the anti-cancer activity of (a type of treatment known as a ) in patients with advanced breast cancer with specific genetic mutations based on a blood, saliva, or tumor test. See the clinicaltrials.gov listing for additional information. This study is no longer enrolling people.
This Study is Open To:
This study is no longer enrolling people.
This Study is Not Open To:
This study is no longer enrolling people.